Meraki Integrative
- Vitamin IV Therapy
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
New York, NY
New York has 13 providers offering eczema (atopic dermatitis) care, from conventional dermatology to integrative protocols. The conventional stack includes topical corticosteroids, topical calcineurin inhibitors (tacrolimus, pimecrolimus), crisaborole (Eucrisa), ruxolitinib cream (Opzelura, FDA-approved 2021), and for moderate to severe disease dupilumab (Dupixent, FDA-approved 2017) and newer oral JAK inhibitors abrocitinib (Cibinqo) and upadacitinib (Rinvoq). Narrowband UVB phototherapy is widely available in New York, with Strong evidence for moderate disease. Regenerative and integrative options include topical growth factors, PRP scalp and face treatments, probiotic protocols, and elimination diets, though evidence for most of these in eczema is Emerging to Insufficient. Dupilumab runs about 37,000 dollars per year list price but is covered by most New York insurers after step therapy. A reputable New York eczema clinic will start with a dermatology evaluation, allergy workup when indicated, and a skin barrier repair plan before escalating to systemics.
Regulatory context
The "other" category is a catchall for regenerative wellness modalities with inconsistent federal oversight. Red light therapy devices (photobiomodulation) have narrow FDA 510(k) clearances for acne, muscle pain, and wound healing, not systemic regeneration. Whole-body cryotherapy is NOT FDA-approved for any medical indication and received an FDA safety communication in July 2016 warning of asphyxiation, frostbite, and burn risks. Ozone therapy is NOT FDA-approved for any medical use and the FDA has stated ozone is a toxic gas with no known useful medical application. Condition-specific regenerative offerings (hair restoration with minoxidil or finasteride, ED care beyond PDE5 inhibitors and shockwave) have varying approval depending on route and drug source.
New York is one of the strictest enforcement states. The Office of Professional Medical Conduct (OPMC) has issued public guidance and pursued disciplinary action against medical spas for corporate practice violations, inappropriate RN or PA delegation, and false advertising of unapproved therapies. Ozone therapy faces heavy scrutiny, and clinics making cancer, Lyme, or autoimmune treatment claims have faced OPMC action and Attorney General consumer protection lawsuits. The NY AG pursues deceptive health claims aggressively under General Business Law Article 22-A.